Data from a study presented at Digestive Disease Week showed use of Torax Medical's Linx magnetic sphincter augmentation device was more effective than double-dose proton pump inhibitor therapy in treating regurgitation in gastroesophageal reflux disease patients. The device demonstrated significantly higher rates of moderate or severe regurgitation resolution compared with double-dose PPI therapy.
Data show positive results for Torax's magnetic sphincter augmentation device
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.